GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jul 28, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-repurchase
TL;DR
GSK is buying back its own stock via Merrill Lynch.
AI Summary
GSK plc announced on July 28, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Merrill Lynch International. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases, which is common for large public companies and does not indicate any immediate negative or positive event.
Key Players & Entities
- GSK plc (company) — The company making the announcement and repurchasing shares.
- Merrill Lynch International (company) — The corporate stockbroker acting on behalf of GSK plc for the share purchases.
- July 2025 (date) — The period during which the report is filed and the transactions occurred.
- 20250728 (date) — The filing date of the report.
FAQ
What specific number of GSK plc ordinary shares were purchased?
The filing states that a 'number' of shares were purchased but does not specify the exact quantity.
What was the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount of the share repurchases.
On what date did the share purchases occur?
The filing indicates the purchases occurred during the month of July 2025, with the report filed on July 28, 2025.
Who acted as GSK plc's stockbroker for these transactions?
Merrill Lynch International acted as GSK plc's corporate stockbroker.
What is the par value of GSK plc's ordinary shares?
The ordinary shares have a par value of 31 1/4 pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 28, 2025 regarding GSK plc (GLAXF).